Fluocinonide NDC 72162-1270

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-1270Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-1270Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-1270-6	72162127006	1 BOTTLE in 1 CARTON (72162-1270-6) / 60 mL in 1 BOTTLEMarketed from Apr 19, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluocinonide
Generic name (nonproprietary): fluocinonide topical solution usp, 0.05%
Active ingredients: Fluocinonide — .5 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209699
Marketing start: Apr 19, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 72162-1270_1050f35c-4bba-4e8c-a51c-89a5466a6f6dSPL ID 1050f35c-4bba-4e8c-a51c-89a5466a6f6dSPL set ID 628bda7e-b670-4f71-bcc4-0290d67655a0RxCUI 310364UNII 2W4A77YPAN
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162127006 followed by a unit qualifier and the quantity

Package 72162-1270-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 7, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fluocinonide topical solution, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209699

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209699
Product	Strength	Form · route	Labeler	Product NDC
Fluocinonidefluocinonide topical solution usp, 0.05%	Fluocinonide .5 mg/mL	SolutionTopical	NuCare Pharmaceuticals, Inc.	68071-3918
Fluocinonidefluocinonide topical solution usp, 0.05%	Fluocinonide .5 mg/mL	SolutionTopical	Encube Ethicals, Inc.	21922-001
Fluocinonidefluocinonide topical solution usp, 0.05%	Fluocinonide .5 mg/mL	SolutionTopical	Bryant Ranch Prepack	63629-9583